Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study

By sjmartinez • December 24, 2025

Abe K, Holmes TH, Nguyen TT; IMPACC Network; Kim-Schulze S, Levy O, Baden LR, Melamed E, Ehrlich LIR, McComsey GA, Sekaly RP, Cairns CB, Haddad EK, Shaw AC, Hafler DA, Montgomery RR, Corry DB, Kheradmand F, Atkinson MA, Brakenridge SC, Agudelo Higuita NI, Metcalf JP, Hough CL, Messer WB, Pulendran B, Nadeau KC, Davis MM, Fernandez-Sesma A, Simon V, Kraft M, Bime C, Calfee CS, Erle DJ, Schaenman J, Reed EF, Ozonoff A, Peters B, Kleinstein SH, Augustine AD, Diray-Arce J, Becker PM, Rouphael N, Maecker HT. Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC study. J Immunol. 2025 Dec 1;214(12):3310-3320. doi: 10.1093/jimmun/vkaf263. PMID: 41166719; PMCID: PMC12726064.

Tags: Cytokines, human, Infectious Diseases, Inflammation, Molecular biology, Publications, viral

Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study

Vakaniaki EH, Barhishindi I, Mubiala A, Malembaka EB, Braunack-Mayer L, Nganga B, Sabiti Nundu S, Brosius I, Bracke S, Bangwen E, De Vos E, Colebunders[...]

Timeliness of yellow fever specimen collection and transport in Ghana, 2018-2022

Judson SD, Schroeder L, Asiedu-Bekoe F, Laryea DO, Boateng G, Gudjinu H, Ossom R, Danquah JF, Dowdy DW, Kenu E. Timeliness of yellow fever specimen[...]

Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

GBD 2023 Lower Respiratory Infections and Antimicrobial Resistance Collaborators. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden[...]